How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,019 results for

"covid 19" OR "novel coronavirus"

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Risk communication and community engagement (RCCE) readiness and response to the 2019 novel coronavirus (??2019-nCoV)??

Risk communication and community engagement (RCCE) readiness and response to the 2019 novel coronavirus (??2019-nCoV)?? Risk communication and community engagement (RCCE) readiness and response to the 2019 novel coronavirus (‎‎2019-nCoV)‎‎ WHO Regional websites / / Risk communication and community engagement (RCCE) readiness and response to the 2019 novel coronavirus (‎‎2019-nCoV)‎‎ © 2020

2020 WHO Coronavirus disease (COVID-19) Pandemic

22. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected

Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected WHO Regional websites / / Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected © 2020

2020 WHO Coronavirus disease (COVID-19) Pandemic

23. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts

Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts WHO Regional websites / / Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts © 2020

2020 WHO Coronavirus disease (COVID-19) Pandemic

24. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected WHO Regional websites / / Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected © 2020

2020 WHO Coronavirus disease (COVID-19) Pandemic

25. Novel coronavirus (2019-nCoV): guidance to assist professionals in advising the general public

Novel coronavirus (2019-nCoV): guidance to assist professionals in advising the general public COVID-19: guidance to assist professionals in advising the general public - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Guidance COVID-19: guidance to assist (...) professionals in advising the general public Advice on how to prevent spread of the infection, what symptoms to look for and what to do. Published 1 February 2020 Last updated 6 February 2020 — From: Documents HTML Details This guidance will assist professionals in providing advice to the public on how to prevent the spread of COVID-19 infection, what symptoms to look for, and what to do if they become unwell in a variety of settings. There may be further information specific to each country in the United

2020 Public Health England

26. Novel coronavirus (2019-nCoV): self-isolation for patients undergoing testing

Novel coronavirus (2019-nCoV): self-isolation for patients undergoing testing COVID-19: self-isolation for patients undergoing testing - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Guidance COVID-19: self-isolation for patients undergoing testing Guidance (...) for how patients should self-isolate while awaiting results of laboratory testing for SARS-CoV-2. Published 31 January 2020 Last updated 31 January 2020 — From: Documents HTML HTML HTML Details This guidance provides advice for individuals who are awaiting results from diagnostic testing for COVID-19 and do not require admission to hospital. COVID-19 was previously referred to as Wuhan novel coronavirus. There may be further information specific to each country in the United Kingdom, as this guidance

2020 Public Health England

27. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts

Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts 1 Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts Interim guidance 17 March 2020 Background WHO has developed this interim guidance to meet the need for recommendations on safe home care for patients with suspected COVID-19 who present with mild symptoms a and on public health measures related to the management (...) of their contacts. This document was adapted from the interim guidance on Middle East respiratory syndrome coronavirus (MERS-CoV) infection that was published in June 2018 1 and is informed by evidence-based guidelines published by WHO, including Infection prevention and control of epidemic- and pandemic- prone acute respiratory diseases in health care, 2 and based on current information on COVID-19. This rapid advice has been updated with the latest information and is intended to guide public health

2020 WHO Coronavirus disease (COVID-19) Pandemic

28. Clinical effect of integrated traditional Chinese medicine and western medicine of 2019 novel coronavirus pneumonia (COVID-19): a network meta-analysis

Clinical effect of integrated traditional Chinese medicine and western medicine of 2019 novel coronavirus pneumonia (COVID-19): a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

29. Chloroquine phosphate for novel coronavirus (COVID-19) pneumonia : a systematic review and meta-analysis of randomised controlled trials

Chloroquine phosphate for novel coronavirus (COVID-19) pneumonia : a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

30. A systematic review of convalescent plasma treatment for SAR coronavirus and MERS coronavirus: a possible reference for a 2019 novel coronavirus (COVID-19) treatment option

A systematic review of convalescent plasma treatment for SAR coronavirus and MERS coronavirus: a possible reference for a 2019 novel coronavirus (COVID-19) treatment option Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

31. Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a systematic review and meta-analysis

Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

32. The risk factors of acquiring severe 2019 novel coronavirus (COVID-19): a meta-analysis

The risk factors of acquiring severe 2019 novel coronavirus (COVID-19): a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

33. The risk factors for death from 2019 novel coronavirus (COVID-19)-infected pneumonia

The risk factors for death from 2019 novel coronavirus (COVID-19)-infected pneumonia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

34. Prevalence and characteristics of fever in novel coronavirus (COVID-19)-infected adult and paediatric patients:a systematic review and meta-analysis of first three-month data of the outbreak

Prevalence and characteristics of fever in novel coronavirus (COVID-19)-infected adult and paediatric patients:a systematic review and meta-analysis of first three-month data of the outbreak Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

35. Prevalence of symptoms and comorbid conditions in novel coronavirus (COVID-19)-infected adult and paediatric patients: a systematic review and meta-analysis of first three-month data of the outbreak

Prevalence of symptoms and comorbid conditions in novel coronavirus (COVID-19)-infected adult and paediatric patients: a systematic review and meta-analysis of first three-month data of the outbreak Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2020 PROSPERO

36. Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials

Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

37. The rehabilitative effects of traditional Chinese exercise in patients with novel coronavirus pneumonia (COVID-19): a systematic review and meta-analysis

The rehabilitative effects of traditional Chinese exercise in patients with novel coronavirus pneumonia (COVID-19): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

38. The psychological impact of 2019 novel coronavirus pneumonia (COVID-19)and mental healthcare strategies: a systematic review and meta-analysis of current evidence

The psychological impact of 2019 novel coronavirus pneumonia (COVID-19)and mental healthcare strategies: a systematic review and meta-analysis of current evidence Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

39. Answering the global call for action in rapid practice guidelines for the management of people with the novel Coronavirus COVID-19: protocol for a rapid systematic review

Answering the global call for action in rapid practice guidelines for the management of people with the novel Coronavirus COVID-19: protocol for a rapid systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

40. A protocol for a systematic review and meta-analysis of Siddha Medicines having Anti viral activity and beneficial in reducing symptoms and selected as candidates for treating novel coronavirus disease (COVID-19)

A protocol for a systematic review and meta-analysis of Siddha Medicines having Anti viral activity and beneficial in reducing symptoms and selected as candidates for treating novel coronavirus disease (COVID-19) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD

2020 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>